Cetrizine

Quick links to important sections

Cetrizine

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cetrizine

What is Cetirizine? Overview

Property Description
Active ingredient Cetirizine Hydrochloride
Forms Tablet, Solution, Syrup, Capsule
Pharmacological Class Second-Generation Antihistamine
General Purpose Relief from allergic hypersensitivity symptoms
Origin Synthetic Compound (Metabolite of Hydroxyzine)

Defining Cetirizine: Identity and Origin

Cetirizine is a synthetic compound administered orally, whose active component is Cetirizine Hydrochloride (C21H25ClN2O3 cdot 2HCl). As a single active ingredient product, it is manufactured chemically, derived as a carboxylic acid metabolite of the older drug, hydroxyzine. This chemical origin reflects its place in the evolution of allergy medications and its distinction as a refined anti-allergic substance.


What Type of Medicine is Cetirizine? The Second-Generation Antihistamine Class

Cetirizine is categorized as a Second-Generation Antihistamine, functioning as a Selective Peripheral H1-Receptor Antagonist. This means the compound specifically targets and blocks H1 receptors in peripheral tissues where histamine triggers allergic reactions. By targeting peripheral receptors, the drug structure is associated with minimal blood-brain barrier penetration, a key distinction from older antihistamines. The effectiveness and safety profile of this class are clinically recognized by health organizations, supported by pharmacological studies published in global databases.


General Purpose and Available Forms

The general purpose of Cetirizine is to provide effective relief from the symptoms of hypersensitivity and common allergic manifestations by interrupting the biological reaction triggered by histamine release. A typical use scenario involves easing symptoms like seasonal runny nose or itchy skin associated with hives. The medication is intended for oral administration and is widely available globally in various dosage forms, including standard Oral Tablets, Chewable Tablets, Oral Capsules, Oral Solution, and Syrup. Because Cetirizine is an INN, it is marketed under numerous popular brands with the same formulation.

Regulatory References

  1. FDA DailyMed Drug Label for Cetirizine

What side effects are possible with Cetrizine?

Possible Side Effects and Safety Information

The safety profile of Cetirizine Hydrochloride is established through clinical trials and post-marketing surveillance, with adverse events formally categorized by frequency and the body system affected, consistent with official regulatory labeling.

Adverse Reaction Classification

Adverse reactions are grouped according to their reported frequency in official product documents. Common reactions (affecting 1 to 10 users in 100) include effects like somnolence (drowsiness), headache, fatigue, dry mouth, and nausea. Reactions classified as Uncommon or Rare (affecting 1 to 10 users in 1,000 to 10,000) involve organ systems such as the nervous system, skin, and gastrointestinal tract.

Serious Adverse Reactions and Safety Constraints

The regulatory labeling documents rare but clinically significant adverse reactions, including severe hypersensitivity reactions such as anaphylactic shock and angioedema, as well as hepatic function abnormalities (including hepatitis). The medication is contraindicated in individuals with a known history of hypersensitivity to the active substance or its parent compound (hydroxyzine). It is also restricted for use in patients with severe renal impairment (creatinine clearance less than 10 mL/min).

Population-Specific Safety Notes

Official labeling requires specific considerations for certain patient groups. Individuals with renal impairment require dosage adjustment due to altered drug clearance. For older adults, official recommendations suggest a lower initial dose, primarily because of the increased likelihood of decreased renal function. Furthermore, some official sources note that intense pruritus or urticaria may occur upon discontinuation of the medicine after long-term daily use.

Overdose and Emergency Response

Overdose and When to Seek Help

This section describes the officially documented manifestations of Cetirizine overdose and the required emergency actions as stated in regulatory labeling.


Documented Manifestations and Serious Outcomes

Overdose presentations are primarily linked to central nervous system (CNS) effects. The most frequently reported manifestations documented in regulatory sources include somnolence (drowsiness), headache, agitation, and diarrhea.

In pediatric patients, regulatory labeling specifically notes signs such as restlessness and irritability as being associated with overexposure.

Though rare, regulatory documentation addresses potential serious outcomes of overdose, which include events such as convulsions and syncope (fainting). Large ingestions are associated with a risk of cardiac effects that may necessitate professional monitoring.


Required Emergency Actions

Official government guidance mandates that individuals seek immediate medical attention or call a Poison Control Center immediately if an overdose is suspected. If the affected person has collapsed, experienced a seizure, or cannot be awakened, emergency services must be contacted without delay.

Management of cetirizine overdose is strictly symptomatic and supportive treatment. Regulatory documents explicitly state that no known specific antidote is available. Medical professionals may consider procedural steps such as gastric lavage or cardiac monitoring based on the severity of the ingestion.

Therapeutic Uses of Cetrizine

Main Uses and Benefits of Cetirizine

Cetirizine is a second-generation antihistamine used to manage symptoms associated with various allergic conditions. Unlike first-generation antihistamines, it is designed to be less likely to cross the blood-brain barrier, which typically results in a lower incidence of sedation while maintaining effectiveness in blocking histamine receptors.

Seasonal and Perennial Allergic Rhinitis

Cetirizine is primarily used to relieve symptoms triggered by airborne allergens such as pollen, mold spores, dust mites, and pet dander. These conditions, often referred to as hay fever or allergic rhinitis, manifest through several common respiratory and ocular symptoms:

  • Sneezing: Helps reduce the frequency and intensity of sneezing fits.
  • Rhinorrhea: Manages a runny nose by decreasing mucus production triggered by allergens.
  • Nasal Congestion: Assists in reducing the swelling of nasal passages.
  • Itching: Addresses itching of the nose and throat.
  • Ocular Symptoms: Relieves red, itchy, and watery eyes associated with allergic conjunctivitis.

Chronic Urticaria (Hives)

In addition to respiratory allergies, cetirizine is utilized in the management of chronic idiopathic urticaria. This condition is characterized by the spontaneous appearance of wheals (hives) and welts on the skin that persist for six weeks or longer without a clear external cause.

The benefits in treating skin-related allergies include:

  • Reduction of Wheals: Decreases the number and size of hives.
  • Pruritus Relief: Significantly reduces the intense itching associated with skin eruptions.
  • Improved Comfort: Assists in the overall management of skin irritation caused by chronic histamine release.

Mechanism of Action and Onset

Cetirizine works by selectively inhibiting peripheral H1 receptors. By preventing histamine from binding to these receptors, it interrupts the allergic cascade that leads to inflammation and discomfort. One of the primary benefits of this medication is its relatively rapid onset of action and its ability to provide symptomatic relief for a continuous 24-hour period, allowing for consistent management of allergy symptoms throughout the day and night.

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Cetirizine

This eligibility profile is determined strictly by the absolute restrictions and conditional requirements documented in official regulatory labeling.

Classification Status and Population Constraint Details (Official Labeling)
Contraindicated Must not use Known hypersensitivity to Cetirizine, Hydroxyzine, or any Piperazine derivatives.
Must not use Patients with severe renal impairment (Creatinine Clearance < 10 mL/min or end-stage renal disease).
Conditional Use Restricted Patients with mild to moderate renal impairment require a restricted-use status involving dose adjustment.
Restricted Patients with hepatic impairment may require dose adjustment or reduction.
Age Thresholds Permitted Adults and adolescents (12 years of age and older).
Permitted Children typically 6 years and over for standard tablets; liquid formulations may be approved from 6 months of age for certain uses.
Specific Status Not Recommended Infants under 6 months of age; safety and efficacy are often not established.
Not Recommended Breastfeeding/Lactating women; the medicine passes into breast milk, and use is not recommended.
Caution Advised Older adults may require professional consultation due to the potential for age-related decline in kidney function.
Comorbidity Limits Caution Advised Patients with predisposing factors for urinary retention (e.g., prostatic hyperplasia) or epilepsy/risk of convulsions should use the medicine with caution.

Connection to the Overall Eligibility Profile

Regulatory documents define patient eligibility through strict contraindications that prohibit use for patients with chemical sensitivities or severely compromised kidney function. For all other populations, eligibility is generally maintained, though it may be subject to conditional status—specifically, restrictions on use in pediatric age groups or mandatory dose adjustments for individuals with existing mild-to-moderate renal or hepatic impairment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define the interaction profile of cetirizine based on specific additive effects and documented pharmacokinetic changes. No drug combinations are formally classified as contraindicated in primary labels.


Documented Interaction Patterns

Interaction Type Interacting Substance/Condition Regulatory Statement of Effect
Pharmacodynamic Central Nervous System (CNS) Depressants, Alcohol Co-administration may result in additive reduction in alertness and impairment of performance, classified as a CNS depressive effect.
Pharmacokinetic Theophylline (400 mg daily) Causes a 16% decrease in cetirizine clearance.
Pharmacokinetic Ritonavir (600 mg twice daily) Increases the extent of cetirizine exposure by approximately 40%.
Absorption Constraint Food Decreases the rate of absorption (reduces maximum concentration), but the total extent of absorption is not affected.
Special Population Note Hepatic Impairment, Geriatric Patients Both groups exhibit documented altered pharmacokinetics, including a prolongation of the elimination half-life and lower total body clearance compared to healthy adults.

Regulatory Findings on Co-Administration

Pharmacokinetic trials documented in prescribing information, including studies with Ketoconazole, Erythromycin, Azithromycin, and Pseudoephedrine, observed no clinically significant adverse interactions with cetirizine. The regulatory evidence generally concludes that many tested transporter or metabolic interactions result in no clinically significant effects, confining the key risks to specific pharmacodynamic and exposure alterations.

Mechanism of Action

How Cetirizine Works

Selective H1-Receptor Blockade

Cetirizine's primary mechanistic focus is its action as a high-affinity antagonist on peripheral H1 histamine receptors . By competitively occupying these receptors, the compound directly blocks the action of histamine, a key inflammatory mediator released during various physiological responses. This interaction interrupts the initial signaling event in the histamine-mediated cascade, thereby dampening excessive signaling within this specific system.


Modulating Inflammatory Pathway Cascades

The blockade of the H1 receptor modifies subsequent molecular cascades that lead to physical physiological manifestations. This drug suppresses signaling sequences that would normally trigger increased capillary permeability, vasodilation, and nerve stimulation. By operating within these well-characterized molecular cascades, Cetirizine contributes to the modulation of overactive physiological responses driven by mediator release.


Peripheral Target Selectivity

Cetirizine, a second-generation compound, is structurally configured to limit its passage across the Blood-Brain Barrier (BBB). This peripheral selectivity means its activity is predominantly confined to biological systems outside the Central Nervous System (CNS). This results in targeted pathway interference in the skin and vasculature while exhibiting low binding to H1 receptors within the CNS.

Dosage and Administration Information

Official Administration Guidelines

Cetirizine is primarily administered via the oral route through various dosage forms, including tablets, capsules, and oral solutions. For certain acute uses and under clinical supervision, an intravenous (IV) injection is an approved route, which must be administered as an IV push over a period of one to two minutes. The oral formulation may be taken with or without food.

Standardized Dosing Regimens

For adults and adolescents 12 years of age and older, the standard dosing regimen is 10 mg once daily, which serves as the maximum recommended daily dose. A 5 mg once-daily dose is also used as an alternative regimen. The dosing for children is age-dependent: children 6 to 11 years typically receive 5 mg or 10 mg once daily. For children 2 to 5 years old, the dose is 2.5 mg once daily, which may be increased to a maximum of 5 mg per day, given as a single dose or 2.5 mg twice daily.

Population-Specific Adjustments

Dose reduction is indicated for specific populations. For adults and adolescents with moderate-to-severe renal impairment, the required oral dose is reduced to 5 mg once daily. Dose modification for hepatic impairment is generally recommended only if concomitant renal impairment is also present. The oral solution or syrup formulation is used for children under 6 years of age to allow for flexible administration of lower doses.

If a dose is missed, the general instruction is to take only the next scheduled dose at the usual time; extra medicine should not be taken to compensate for a forgotten dose.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Cetirizine


Evidence for use in Seasonal and Perennial Allergic Rhinitis

Research examining Cetirizine for use in Seasonal Allergic Rhinitis (SAR) and Perennial Allergic Rhinitis (PAR) includes short-term Randomized Controlled Trials (RCTs) and systematic reviews. These studies were designed to evaluate short-term symptom patterns in patient groups, including adults, adolescents, and children aged two years and older. Studies measured outcomes related to physical discomfort, focusing on symptoms such as sneezing, runny nose (rhinorrhea), nasal itching, and related ocular symptoms (itchy, watery eyes).

Studies reported measured changes in symptoms over defined short periods. Trials described patterns observed in the measured outcomes in both the actively treated group and the control group. Research includes reports on changes measured during the study period related to total symptom severity scores. However, existing studies provide limited insight into the necessity of long-term use. Long-term effects are not fully established, and there is limited information for outcomes beyond the typical 4-to-6-week study duration.


Evidence for use in Chronic Hives (Urticaria)

Cetirizine was studied for use in managing the skin manifestations of Chronic Idiopathic Urticaria (CIU), commonly known as chronic hives. Research examined this condition, which is characterized by fluctuating or episodic manifestations, mainly through intermediate-term RCTs. Trials reported observed measurements related to pruritus severity (itching) and the number/size of wheals (hives) over four to six weeks. The core research base includes data for standard treatment periods, but long-term effects are not fully established regarding the maintenance of symptom control beyond the intermediate trial length.


Evidence in Special Populations

Research has explored the use of Cetirizine across different age groups, including specific studies that included infants down to six months of age in some regulatory contexts, and studies involving older adults. For the youngest children, sample sizes were modest in the controlled trials, and the data for certain groups remain insufficient to draw wide-ranging conclusions. Research describes group patterns, not personal outcomes; it does not determine whether an individual will respond similarly.

Key Studies & References

  1. H1-antihistamines for chronic spontaneous urticaria: an abridged Cochrane Systematic Review
  2. Cetirizine: MedlinePlus Drug Information

Frequently Asked Questions (FAQ)

Common questions about Cetrizine (FAQ)

Q: Does Cetrizine cause drowsiness or make you sleepy?

A: Yes, official labeling lists somnolence, which is the technical term for drowsiness or sleepiness, as a common adverse reaction. According to clinical trial data summarized in regulatory documents, this effect was reported in 1 to 10 users out of every 100.

Q: Is it true that Cetrizine can affect driving ability?

A: Official warnings advise exercising due caution when driving a car or operating potentially dangerous machinery. This caution is based on reported somnolence or sedation in clinical trials, which indicates the potential for impairment of performance and alertness.

Q: How quickly does Cetrizine start to work after taking it?

A: Based on product summaries and pharmacokinetic data, the onset of effects is generally described as beginning quickly, typically within thirty minutes after the medicine is taken.

Q: How long do the effects of Cetrizine last?

A: The official product labeling indicates that Cetirizine is formulated to provide symptom relief that lasts for 24 hours. This duration is consistent with its labeling for once-daily administration.

Q: Can Cetrizine be taken long-term?

A: Official research overviews indicate that long-term effects beyond the typical 4-to-6-week study duration are not fully established. Furthermore, official labeling notes the potential for intense itching (pruritus) upon stopping the medicine after long-term use, a phenomenon noted in regulatory documents.

Q: Can I take Cetrizine if I am taking other cold medicines?

A: Regulatory trials documented no clinically significant adverse interactions with tested ingredients common in cold medicines, such as pseudoephedrine. However, co-administration with central nervous system (CNS) depressants may result in an additive reduction in alertness, as noted in regulatory warnings.

Q: What are the concerns about taking Cetrizine during pregnancy?

A: Official labeling advises patients who are pregnant or planning to become pregnant to consult a health professional before use. The official guidance strictly states that patients should consult a health professional before use.

Q: Does Cetrizine stop working if you use it for a long time?

A: Regulatory documents do not contain explicit statements about the development of tolerance. However, the official labeling notes the reported risk of new onset intense itching (pruritus) occurring in some patients within a few days of stopping the medicine after long-term use.

Q: Can Cetrizine affect the results of allergy skin tests?

A: Because Cetirizine blocks histamine activity, it can interfere with the results of an allergy skin test. Official medical practice generally indicates that this type of medicine may need to be stopped before allergy skin testing, as its mechanism of action can interfere with the test results.

Q: Is it true that taking Cetrizine at night can reduce daytime drowsiness?

A: The medicine is approved for once-daily administration. Since drowsiness (somnolence) is a possible common adverse reaction, taking the dose in the evening is a strategy that has been described for managing the reported somnolence effect, given the drug's once-daily administration.

Q: What documentation exists on Cetrizine's safety for long-term use?

A: Official research overviews state that existing studies provide limited insight into the necessity of long-term use, and long-term effects are not fully established beyond the typical trial length of 4 to 6 weeks.

Q: How does Cetrizine compare to other antihistamines regarding heart rhythm side effects?

A: Cetirizine is classified as a Second-Generation Antihistamine. This class is described in authoritative reviews as having a profile that generally distinguishes it from older antihistamine classes, particularly concerning central nervous system effects, due to its peripheral selectivity.

Q: Is Cetrizine the same kind of medicine as loratadine?

A: Both Cetirizine and Loratadine are categorized as Second-Generation Antihistamines. This means they both function as Selective Peripheral H1-Receptor Antagonists, targeting the same histamine receptors outside the brain.

Q: What is the difference between Cetrizine and diphenhydramine?

A: Cetirizine is classified as a Second-Generation Antihistamine, while diphenhydramine is a First-Generation Antihistamine. Official documents describe Second-Generation compounds as having limited passage across the Blood-Brain Barrier, a key distinction from the older class.

Q: What is the chemical difference between Cetrizine and levocetirizine?

A: Cetirizine is a racemic mixture, which is a compound that includes two mirror-image forms. Levocetirizine is described as the active mirror-image component, or enantiomer, of the cetirizine compound.

Q: Are there any food or drink restrictions while taking Cetrizine?

A: Regulatory documents advise avoiding alcoholic drinks due to the potential for increased drowsiness and impairment of alertness. The medicine may generally be taken with or without food, as food only affects the rate of absorption, not the overall amount absorbed.

Q: Is Cetrizine generally considered less sedating than older allergy medicines?

A: Cetirizine is categorized as a Second-Generation Antihistamine, a class structurally configured for limited passage across the blood-brain barrier. This limited passage is the key factor that distinguishes it from the more sedating older antihistamine classes.

Q: What are the signs of a non-severe allergic reaction to Cetrizine?

A: While serious reactions are rare, the official safety profile includes reports of non-severe reactions to monitor, such as skin rash, itching, and hives (urticaria). If any changes or reactions occur, the patient information advises consulting a health professional.

Q: Can taking Cetrizine affect my ability to concentrate?

A: Official warnings advise caution due to the reported occurrence of somnolence (drowsiness) and the potential for a reduction in alertness and impairment of Central Nervous System (CNS) performance.

Q: Why is Cetrizine preferred over first-generation antihistamines in many cases?

A: Cetirizine is a Second-Generation Antihistamine, a class characterized in regulatory documents by its selective peripheral H1-receptor targeting and limited passage across the blood-brain barrier. These properties offer a distinct profile compared to older classes.

Q: Can Cetrizine be used to help with sleep?

A: The official indications for Cetirizine are for the relief of symptoms related to allergic conditions, such as allergic rhinitis and chronic urticaria (hives). Use of the medicine as a sleep aid is not an approved indication.

Q: Why is Cetrizine sometimes marketed under different brand names?

A: The active ingredient is Cetirizine Hydrochloride, which is an International Nonproprietary Name (INN) or generic name. Since the medicine is widely available, this single compound is formulated and sold globally by different manufacturers under various popular brand names.

Q: Does Cetrizine contain lactose or gluten?

A: Official labeling for some oral tablet formulations lists anhydrous lactose as an inactive ingredient (excipient). Information regarding gluten content is generally not provided in the same official regulatory overviews.

Q: Are there studies on Cetrizine use in breastfeeding mothers?

A: Authoritative databases, such as the NIH-supported LactMed, contain reports of studies indicating that the medicine passes into breast milk. These sources advise caution due to the potential for infant drowsiness.

Q: Is there a link between Cetrizine use and feeling irritable?

A: Official safety data lists agitation as an uncommon adverse reaction, reported in 1 to 10 users out of every 1,000. This reaction is one of many potential effects categorized under the nervous system.

Q: Does Cetrizine work immediately or build up in the system?

A: The medicine acts quickly, with effects generally starting within thirty minutes after administration. At the same time, regulatory information notes that steady-state plasma levels (consistent concentration in the blood) are documented to occur within 3 days of regular, continuous use.

How should Cetrizine be stored and disposed of?

How to Store and Dispose of Cetirizine

The storage and disposal of Cetirizine must adhere strictly to official regulatory guidelines to maintain product quality and safety.

Mandatory Storage Conditions

Cetirizine products are required to be stored at controlled room temperature, typically between 20°C to 25°C (68°F to 77°F). It is mandatory to protect the medicine from light and high humidity, and to avoid excessive heat or freezing to maintain stability. The product should be kept in its original container and the bottle must be tightly closed.

Child Safety and Disposal

The medication must always be stored out of the sight and reach of children. Regarding disposal, unused or expired Cetirizine must not be thrown into household waste or flushed down the toilet. Instead, the product should be disposed of in accordance with local environmental regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Cetrizine found in:

A-Z Index: